News Source
EXCERPT:
Do American pharmaceutical companies conducting clinical trials on drugs in China help the CCP’s military capability? A bipartisan group of lawmakers wants to know, and they’ve opened an investigation into drugmakers, including Merck, Eli Lilly, Pfizer, Bristol Myers Squibb, and AbbVie (a spinoff of Abbott Laboratories), and are demanding that they detail their policies and due diligence efforts in their overseas operations.
Rep. John Moolenaar (MI-02), chair of the China Select Committee, is leading the charge:
Select Committee Chairman @RepMoolenaar sent a letter to @abbvie, which conducted clinical trials at Chinese military hospitals and in Xinjiang, the epicenter of the CCP’s genocide against Uyghurs.
Our investigation requests information on the company’s policies and due… pic.twitter.com/INYpACRRXR
— Select Committee on China (@ChinaSelect) June 30, 2026
